164 related articles for article (PubMed ID: 37526671)
1. Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases.
Fitzpatrick D; Seebah S; Lannon R; Mc Carroll K
Osteoporos Int; 2023 Oct; 34(10):1807-1808. PubMed ID: 37526671
[No Abstract] [Full Text] [Related]
2. Atypical femoral fracture in a bisphosphonate-naïve patient on denosumab for osteoporosis.
Kumar S; Chang R; Reyes M; Diamond T
Arch Osteoporos; 2022 Oct; 17(1):131. PubMed ID: 36180610
[TBL] [Abstract][Full Text] [Related]
3. Atypical Femoral Fractures : Three Cases And A Review Of Literature.
Van Lieshout M; Putzeys G; Goemaere S; Van Der Straeten C; Audenaert E
Acta Orthop Belg; 2017 Dec; 83(4):558-567. PubMed ID: 30423662
[TBL] [Abstract][Full Text] [Related]
4. Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease.
Lai KH; Chiang CY; Yang RS; Yang KC; Wu CC
Acta Clin Belg; 2019 Oct; 74(5):370-374. PubMed ID: 30336748
[No Abstract] [Full Text] [Related]
5. Bilateral Atypical Femur Fractures After Denosumab in a Bisphosphonate Naive Patient: A Case Report.
Goh JKM; Koh JSB; Ng ACM; Png MA; Howe TS
Calcif Tissue Int; 2022 Jul; 111(1):96-101. PubMed ID: 35132455
[TBL] [Abstract][Full Text] [Related]
6. Atypical femoral fracture.
Khan AA; Kaiser S
CMAJ; 2017 Apr; 189(14):E542. PubMed ID: 28396331
[No Abstract] [Full Text] [Related]
7. Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication.
Silverman S; Kupperman E; Bukata S
Cleve Clin J Med; 2018 Nov; 85(11):885-893. PubMed ID: 30395525
[TBL] [Abstract][Full Text] [Related]
8. MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.
Adler RA
Eur J Endocrinol; 2018 Mar; 178(3):R81-R87. PubMed ID: 29339529
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
Ramchand SK; Chiang CY; Zebaze RM; Seeman E
Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389
[TBL] [Abstract][Full Text] [Related]
10. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
Horning JA; Czajka J; Uhl RL
Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
[No Abstract] [Full Text] [Related]
11. Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer.
Kordoni M; Rigakos G; Kim YHM; Kaklamanis L; Nikolatou-Galitis O; Hadjiyassemi L; Labropoulos S; Razis E
Anticancer Res; 2018 Nov; 38(11):6439-6444. PubMed ID: 30396969
[TBL] [Abstract][Full Text] [Related]
12. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
[TBL] [Abstract][Full Text] [Related]
13. Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report.
Piponov HI; Goldstein JM; Eisenberg GM
Osteoporos Int; 2020 Nov; 31(11):2263-2267. PubMed ID: 32561954
[TBL] [Abstract][Full Text] [Related]
14. Amid Osteoporosis Treatment Crisis, Experts Suggest Addressing Patients' Bisphosphonate Concerns.
Abbasi J
JAMA; 2018 Jun; 319(24):2464-2466. PubMed ID: 29874373
[No Abstract] [Full Text] [Related]
15. Burden of bisphosphonate-associated femoral fractures.
Shkolnikova J; Flynn J; Choong P
ANZ J Surg; 2013 Mar; 83(3):175-81. PubMed ID: 23216704
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
Selga J; Nuñez JH; Minguell J; Lalanza M; Garrido M
Osteoporos Int; 2016 Feb; 27(2):827-32. PubMed ID: 26501556
[TBL] [Abstract][Full Text] [Related]
17. Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.
Hanley DA; McClung MR; Davison KS; Dian L; Harris ST; Miller PD; Lewiecki EM; Kendler DL;
Am J Med; 2017 Jul; 130(7):862.e1-862.e7. PubMed ID: 28359721
[TBL] [Abstract][Full Text] [Related]
18. Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates.
Parrón Cambero R; Rey López A; Tomé-Bermejo F; Cibantos Martínez R
Eur J Orthop Surg Traumatol; 2013 Nov; 23 Suppl 2():S219-23. PubMed ID: 23412218
[TBL] [Abstract][Full Text] [Related]
19. Denosumab-Associated Peri-Implant Atypical Femur Fracture: A Case Report.
Dupaix JP; Opanova MI; Lee LSK; Christensen K
Hawaii J Health Soc Welf; 2019 Nov; 78(11 Suppl 2):47-51. PubMed ID: 31773111
[TBL] [Abstract][Full Text] [Related]
20. Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study.
Kang JS; Won YY; Kim JO; Min BW; Lee KH; Park KK; Song JH; Kim YT; Kim GH
Int Orthop; 2014 Jun; 38(6):1247-53. PubMed ID: 24464018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
